Medicine information
Uses & overview
VILDIABATE PIO is an oral antidiabetic formulation from Steris Healthcare containing Vildagliptin 50 mg and Pioglitazone Hydrochloride 15 mg per tablet. It combines two medicines that work through different mechanisms to support blood glucose control in adults with type 2 diabetes mellitus, when prescribed by a qualified healthcare professional. Composition Vildagliptin: 50 mg Pioglitazone Hydrochloride: 15 mg Dosage Form: Tablets Brand Name: VILDIABATE PIO Company Name: Steris Healthcare Therapeutic Category: Oral Antidiabetic Medicine How It Works Vildagliptin is a DPP-4 inhibitor that helps regulate blood glucose by supporting glucose-dependent insulin release and reducing glucagon secretion. Pioglitazone is a thiazolidinedione that improves the body's sensitivity to insulin, helping the body use insulin more effectively.
How to use
Take VILDIABATE PIO Tablets exactly as prescribed by your doctor. Swallow the tablet with water, with or without food, according to your prescribed treatment schedule. Do not change the dose, discontinue treatment, or take additional tablets without consulting your healthcare professional. Follow your recommended diet and exercise plan and monitor blood glucose levels as advised. If you miss a dose, follow your doctor's instructions or the patient information leaflet rather than doubling the next dose. Regular medical follow-up may be necessary to assess blood glucose control, liver function, and other relevant health parameters.
Storage
Store VILDIABATE PIO Tablets according to the storage instructions printed on the product packaging. Keep the tablets in their original packaging, protected from excessive heat and moisture. Keep the medicine out of reach of children. Do not use the tablets after the expiry date or if the packaging is damaged.
